Advertisement

Topics

$BIIB & C4 Therapeutics Enter into Strategic Collaboration to Discover and Develop Potential New Treatments for Neurological Conditions. C4 will receive up to $415M https://globenewswire.com/news-release/2019/01/04/1680580/0/en/Biogen-and-C4-Therapeutics-

07:32 EST 4 Jan 2019 | Odi Bruckman

& C4 Therapeutics Enter into Strategic Collaboration to Discover and Develop Potential New Treatments for Neurological Conditions. C4 will receive up to $415M https://globenewswire.com/news-release/2019/01/04/1680580/0/en/Biogen-and-C4-Therapeutics-Enter-into-Strategic-Collaboration-to-Discover-and-Develop-Potential-New-Treatments-for-Neurological-Conditions.html …

Original Article: $BIIB & C4 Therapeutics Enter into Strategic Collaboration to Discover and Develop Potential New Treatments for Neurological Conditions. C4 will receive up to $415M https://globenewswire.com/news-release/2019/01/04/1680580/0/en/Biogen-and-C4-Therapeutics-

NEXT ARTICLE

More From BioPortfolio on "$BIIB & C4 Therapeutics Enter into Strategic Collaboration to Discover and Develop Potential New Treatments for Neurological Conditions. C4 will receive up to $415M https://globenewswire.com/news-release/2019/01/04/1680580/0/en/Biogen-and-C4-Therapeutics-"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...